New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 12, 2014
10:49 EDTEGRXEagle Pharmaceuticals price target raised to $30 from $22 at Cantor
Cantor said Ryanodex, which Eagle Pharmaceuticals has priced significantly above the firm's initial expectations, is planned to launch at the end of this month and should help offset some of the losses associated with argatroban. The firm raised its price target on Eagle to $30 from $22 and reiterates its Buy rating on the shares.
News For EGRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 20, 2015
07:02 EDTEGRXEagle Pharmaceuticals price target raised to $75 from $55 at Piper Jaffray
Subscribe for More Information
April 14, 2015
11:05 EDTEGRXEagle Pharmaceuticals price target raised to $65 from $51 at Cantor
Subscribe for More Information
08:03 EDTEGRXTeva, Eagle announce NDA for bendamustine HCI accepted for filing
Subscribe for More Information
April 13, 2015
13:25 EDTEGRXEagle Pharmaceuticals appoints Fibrocell CEO to board of directors
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use